Just In
- 35 min ago Mahavir Jayanti 2024: Date, Time, History, Celebrations And Teachings Of Lord Mahavir In Jainism
- 1 hr ago Parineeti Chopra Saree Looks: Check Amar Singh Chamkila Actor's Regal Fashion Statements
- 3 hrs ago Vidya Balan's 'Do Aur Do Pyaar' Urban Boho Style Avatar Is Relatable And Inspiring, Check Her Modern Avatar!
- 11 hrs ago Golden Rules To Follow For Happy Marriage For A Long Lasting Relationship
Don't Miss
- Movies Devara Part 1: Jr NTR To Groove With Pooja Hegde In Janhvi Kapoor-Starrer Actioner For A Special Song; Details
- Sports ONE Friday Fights 59 Results: Yamin Beats Ouraghi In Freak Stoppage, Yodthongthai Topples Petnamngam
- News Bengaluru Traffic Alert: Avoid These Roads On April 20 Between 1 PM To 7 PM
- Automobiles Ford Mustang 60th Anniversary Package – Limited To Just 1,965 Units
- Technology Confirmed List of Products Launching at Xiaomi Smarter Living 2024
- Finance Daily Relative Strength Index RSI In A Bullish Mode of This Pharma Stock; Buy For TP Rs 635-685
- Education Exam Pressure Does Not Exist; Studying Punctually is Crucial; Says Aditi, the PSEB 2024 Topper
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
Paxlovid: South Korea Gets First Supply Of Pfizer's COVID-19 Pills; Read Details
South Korea on Thursday received its first supply of Pfizer's antiviral COVID-19 pills to treat patients with mild or moderate symptoms. Health officials have described the Paxlovid pills as a potentially important tool to suppress hospitalisations and deaths, as the country braces for another possible surge in infections driven by the contagious omicron variant.
South Korea's initial supply is enough to support the required five-day treatment courses for 21,000 people. Officials say another batch of pills, enough to provide the required five-day courses for 10,000 people, will come by the end of January 2022.
Workers were seen unloading containers of the pills from a plane at Incheon International Airport. The pills will be moved to a pharmaceutical warehouse in central South Korea before being administered to patients nationwide starting Friday. Because supplies of Paxlovid will be tight at the start amid global shortages, the pills will initially be available only to patients 65 years or older who are being treated at home or in shelters for mild or moderate symptoms.
“In clinical trials, this drug has showed it could reduce the risk of hospitalisations or deaths by 88%, so we are hoping for a similar level of (real world) effectiveness,” said Lim Sook-young, a senior official in the Korea Disease Control and Prevention Agency.
South Korea's Ministry of Food and Drug Safety is also reviewing whether to grant an emergency use authorisation for Merck's antiviral COVID-19 pills, Molnupiravir.
ALSO READ: Molnupiravir Not To Be Included In COVID-19 Clinical Management Protocol: ICMR
South Korea grappled in recent months with a devastating delta-driven surge that caused a spike in hospitalisations and deaths, but transmissions have slowed after officials imposed the country's strictest-ever virus restrictions in mid-December. The rules include a ban on private social gatherings of five or more people nation-wide and a requirement that restaurants, coffee shops, gyms and karaoke venues close by 9 pm.
But officials say the virus could regain speed in the coming weeks due to the spread of the omicron variant, which is likely to become the country's dominant strain by the end of this month. Son Youngrae, a senior Health Ministry official, said around 12% of infections confirmed last week were of the omicron strain, which he said could account for more than 50% of cases within one or two weeks.
Experts say omicron, which has already become dominant in many countries, spreads more easily than other coronavirus strains. It also more easily infects those who have been vaccinated or had previously been infected by prior versions of the virus.
However, early studies show omicron is less likely to cause severe illness than the delta variant, and that vaccination and booster shots still offer strong protection from serious illness, hospitalisation and death.
The KDCA reported 4,167 new cases of the virus on Thursday, including a record 391 cases linked to international passengers. Officials say nearly 90% of cases linked to international passengers were omicron cases.
(AP) VM VM PTI
- pregnancy parentingMysterious Pneumonia Outbreak In China: What Are The Long-Term Effects Of Pneumonia In Children?
- healthCan You Get Back COVID-Related Loss Of Sense Of Smell And Taste (Parosmia)? Looks Like You Can!
- healthDid Covid-10 Vaccination Increase Risk Of Sudden Deaths In Young Adults? ICMR Finds This..
- wellnessDelhi Air Pollution, Air Quality Very Poor: Do Covid Masks Help Reduce Pollution Side Effects?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthWhat Is Disease X? 20 Times More Deadlier Than Covid 19; Can Cause 50 Million Deaths, Does It Have Vaccine?
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthDo You Pick Your Nose? Stop! It Can Increase COVID Risk
- healthEris Variant: WHO Alarms New Covid Wave; Should India Be Concerned About This Pandemic
- healthVitamin D Deficiency Linked With Increased Risk Of Long COVID
- healthCOVID Surge In India: Do You Need A COVID-19 Booster Shot?
- healthCOVID-19: IMA Cites 3 Reasons Behind Recent Surge In Covid-19 Cases: What Are They?